Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement

The optimal design and patient selection for interventional trials in radiogenomics seem trivial at first sight. However, radiogenomics do not give binary information like in e.g. targetable mutation biomarkers. Here, the risk to develop severe side effects is continuous, with increasing incidences...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Radiother Oncol
Hlavní autoři: De Ruysscher, Dirk, Defraene, Gilles, Ramaekers, Bram L.T., Lambin, Philippe, Briers, Erik, Stobart, Hilary, Ward, Tim, Bentzen, Søren M, Van Staa, Tjeerd, Azria, David, Rosenstein, Barry, Kerns, Sarah, West, Catharine
Médium: Artigo
Jazyk:Inglês
Vydáno: 2016
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5557371/
https://ncbi.nlm.nih.gov/pubmed/27979370
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.radonc.2016.11.003
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky